Tesamorelin × profoundaminos.com — lab test, January 2025
This lab doesn't publish a public lookup, so we can't confirm the certificate against the lab's own record. The document was reviewed before publication, but it rests on our review alone.
What portal verification means →Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 5 mg · Lab measured 6.43 mg
129% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 1.6 mg using the measured mass, against 1.3 mg on the label — 29% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 2025-01-23 |
|---|---|
| Portal lookup | Lab has no portalThis laboratory publishes no public lookup, so the report cannot be confirmed independently. |
| PDF vs portal | MZ Biolabs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tesamorelin from profoundaminos.com, performed by MZ Biolabs on January 28, 2025. Reported purity: 88.28%. Purity falls below the 95% specification commonly applied to research peptides. Net content: 6.43 mg against 5 mg labeled (129% of label). Tested content exceeds the labeled amount by 29%. Batch 2025-01-23. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of Tesamorelin from profoundaminos.com
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| SP-3281 | 31 Mar 2026 | Trust Pointe Analytics | 99.12% | 104% | Unverified |
| SP-2753 | 6 Jan 2026 | Trust Pointe Analytics | 99.735% | 104% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion